Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol

被引：75

作者：

Anderson, FD ^{[1
]}

Gibbons, W

Portman, D

机构：

[1] Eastern Virginia Med Sch, Jones Inst Reprod Med, Norfolk, VA 23507 USA

[2] Columbus Ctr Womens Hlth Res, Columbus, OH 43213 USA

来源：

CONTRACEPTION | 2006年 / 73卷 / 03期

关键词：

Seasonique (TM); extended regimen; oral contraceptive; ethinyl estradiol; pregnancy;

D O I：

10.1016/j.contraception.2005.09.010

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Objective: To assess the efficacy and safety of Seasonique (TM), a 91-day extended-regimen oral contraceptive (OC) utilizing continuous low-dose ethinyl estradiol (EE) during the typical hormone-free interval. Methods: A multicenter, open-label, 1-year study of Seasonique (TM) [30 mu g EE/150 mu g levonorgestrel (LNG)] for 84 days followed by EE 10 mu g for 7 days was conducted in sexually active, adult women of childbearing potential. All patients completed daily electronic diaries to monitor compliance and bleeding. Results: Method failure rate was 0.78 (Pearl index) and 0.64% (life table analysis). Cycle control and safety of the regimen were similar to that reported for other OCs. Conclusion: This study demonstrates that Seasonique (TM) is effective, safe and well tolerated for the prevention of pregnancy. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：229 / 234

页数：6

共 25 条

[11] Ovarian activity in women taking an oral contraceptive containing 20 μg ethinyl estradiol and 150 μg desogestrel:: Effects of low estrogen doses during the hormone-free interval [J].

Killick, SR ;

Fitzgerald, C ;

Davis, A .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (01) :S18-S24

[12] A RANDOMIZED CROSSOVER COMPARISON OF 2 LOW-DOSE ORAL-CONTRACEPTIVES UPON HORMONAL AND METABOLIC PARAMETERS .1. EFFECTS UPON SEXUAL HORMONE LEVELS [J].

KUHL, H ;

GAHN, G ;

ROMBERG, G ;

MARZ, W ;

TAUBERT, HD .

CONTRACEPTION, 1985, 31 (06) :583-593

[13] Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial [J].

Kwiecien, M ;

Edelman, A ;

Nichols, MD ;

Jensen, JT .

CONTRACEPTION, 2003, 67 (01) :9-13

[14]

Perone Nicola, 1994, P5

[15] Ortho Evra™ /Evra™ versus oral contraceptives:: follicular development and ovulation in normal cycles and after an intentional dosing error [J].

Pierson, RA ;

Archer, DF ;

Moreau, M ;

Shangold, GA ;

Fisher, AC ;

Creasy, GW .

FERTILITY AND STERILITY, 2003, 80 (01) :34-42

[16] Manipulation of the pill-free interval in oral contraceptive pill users: The effect on follicular suppression [J].

Schlaff, WD ;

Lynch, AM ;

Hughes, HD ;

Cedars, MI ;

Smith, DL .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) :943-949

[17] Use of an oral contraceptive containing drospirenone in an extended regimen [J].

Sillem, M ;

Schneidereit, R ;

Heithecker, R ;

Mueck, AO .

EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2003, 8 (03) :162-169

[18] Shorter pill-free interval in combined oral contraceptives decreases follicular development [J].

Spona, J ;

Elstein, M ;

Feichtinger, W ;

Sullivan, H ;

Ludicke, F ;

Muller, U ;

Dusterberg, B .

CONTRACEPTION, 1996, 54 (02) :71-77

[19] Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding [J].

Sulak, PJ ;

Carl, J ;

Gopalakrishnan, I ;

Coffee, A ;

Kuehl, TJ .

CONTRACEPTION, 2004, 70 (04) :281-287

[20] Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms [J].

Sulak, PJ ;

Kuehl, TJ ;

Ortiz, M ;

Shull, BL .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (06) :1142-1149

← 1 2 3 →